SNAI2 and colorectal carcinoma: This study aimed to examine the immunohistochemical expression of epithelial–mesenchymal transition biomarkers: P4HA2 and SLUG in colorectal carcinoma (CRC) specimens, then to assess their relation to clinicopathological features including KRAS mutations and patients’ survival, and finally to study the correlation between them in CRC.